UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection

Nature communications, 2021-07, Vol.12 (1), p.4372-4372, Article 4372

2021

Volltextzugriff (PDF)

The emerging role of the inflammasome in kidney diseases

Current opinion in nephrology and hypertension, 2014-05, Vol.23 (3), p.204-210

2014

Volltextzugriff (PDF)

Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis

The Journal of clinical investigation, 2022-07, Vol.132 (13), p.1-18

2022

Volltextzugriff (PDF)

The impact of education and clinical decision support on the quality of positive antinuclear antibody referrals

Clinical rheumatology, 2021-07, Vol.40 (7), p.2921-2925

2021

Volltextzugriff (PDF)

A single center pilot study: assessing resident needs and faculty perceptions to improve training in rheumatology

BMC medical education, 2023-05, Vol.23 (1), p.351-351, Article 351

2023

Volltextzugriff (PDF)

Vimentin Is a Dominant Target of In Situ Humoral Immunity in Human Lupus Tubulointerstitial Nephritis

Arthritis & rheumatology (Hoboken, N.J.), 2014-12, Vol.66 (12), p.3359-3370

2014

Volltextzugriff (PDF)

Refractory dermatomyositis responsive to anifrolumab

JAAD Case Reports, 2024-01, Vol.43, p.27-29

2024

Volltextzugriff (PDF)

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus

Clinical & developmental immunology, 2012-01, Vol.2012 (2012), p.1-11

2012

Volltextzugriff (PDF)

504 Specific in situ inflammatory architectures predict progression to renal failure in human lupus nephritis

Lupus science & medicine, 2021-11, Vol.8 (Suppl 2), p.A14-A15

2021

Volltextzugriff (PDF)

Cellular aspects of the pathogenesis of lupus nephritis

Current opinion in rheumatology, 2021-03, Vol.33 (2), p.197-204

2021

Volltextzugriff (PDF)

Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations

Journal of autoimmunity, 2015-06, Vol.60, p.51-58

2015

Volltextzugriff (PDF)

Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus

Clinical & developmental immunology, 2012-01, Vol.2012 (2012), p.1-9

2012

Volltextzugriff (PDF)

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients

Frontiers in immunology, 2013, Vol.4, p.309-309

2013

Volltextzugriff (PDF)

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis (HUM1P.314)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.52-52.14

2014

Volltextzugriff (PDF)

Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis

Lupus, 2020-05, Vol.29 (6), p.569-577

2020

Volltextzugriff (PDF)

Bcl‐2 as a Therapeutic Target in Human Tubulointerstitial Inflammation

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2740-2751

2016

Volltextzugriff (PDF)

Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial

The Lancet. Rheumatology, 2024-03, Vol.6 (3), p.e168-e177

2024

Volltextzugriff (PDF)

Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus

Journal of rheumatology, 2012-06, Vol.39 (6), p.1238-1240

2012

Volltextzugriff (PDF)

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus

Journal of immunology research, 2012, Vol.2012 (2012), p.1-11

2012

Volltextzugriff (PDF)

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis

Arthritis research & therapy, 2014-01, Vol.16 (S1), p.A18-A18, Article A18

2014

Volltextzugriff (PDF)

The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings

The American surgeon, 2003-03, Vol.69 (3), p.225-9; discussion 229-30

2003

Volltextzugriff (PDF)

Refractory dermatomyositis responsive to anifrolumab

JAAD case reports, 2024, Vol.43, p.27-29

2024

Volltextzugriff (PDF)

Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus

Journal of immunology research, 2011, Vol.2012 (2012), p.1-9

2011

Volltextzugriff (PDF)

The False Negative Technetium-99m-Sestatnibi Scan in Patients with Primary Hyperparathyroidism: Correlation with Clinical Factors and Operative Findings

The American surgeon, 2003-03, Vol.69 (3), p.225-230

2003

Volltextzugriff (PDF)

Acute Pancreatitis with Normal Amylase and Lipase

The Medicine forum (Philadelphia, Pa.), 2009, Vol.11 (1)

2009

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection

The emerging role of the inflammasome in kidney diseases

Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis

The impact of education and clinical decision support on the quality of positive antinuclear antibody referrals

A single center pilot study: assessing resident needs and faculty perceptions to improve training in rheumatology

Vimentin Is a Dominant Target of In Situ Humoral Immunity in Human Lupus Tubulointerstitial Nephritis

Refractory dermatomyositis responsive to anifrolumab

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus

504 Specific in situ inflammatory architectures predict progression to renal failure in human lupus nephritis

Cellular aspects of the pathogenesis of lupus nephritis

Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations

Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis (HUM1P.314)

Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis

Bcl‐2 as a Therapeutic Target in Human Tubulointerstitial Inflammation

Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial

Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis

The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings

Refractory dermatomyositis responsive to anifrolumab

Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus

The False Negative Technetium-99m-Sestatnibi Scan in Patients with Primary Hyperparathyroidism: Correlation with Clinical Factors and Operative Findings

Acute Pancreatitis with Normal Amylase and Lipase

Suchergebnisse filtern